Researchers have discovered a link between two key pathways that regulate the immune system in mammals – a finding that impacts understanding of chronic inflammatory bowel diseases.
Faculty in Cornell’s Action Research Collaborative (ARC) joined New York City and State policymakers and community members for ARC’s second symposium on June 22. The annual symposium is an opportunity for researchers, policymakers and community stakeholders to share their knowledge and advance equity in areas like nutrition and health, housing and social services, and youth development.
An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.
From inspiring lectures to thought-provoking exhibitions and much-anticipated renovations (plus the unveiling of the Dragon Annex), we're diving into a semester filled with opportunities not to be missed.
Specialized nursing facility clinicians, or SNFists, may decrease the likelihood of nursing home residents experiencing stressful hospitalizations and improve the quality of life in their last days, according to researchers from Weill Cornell Medicine.
A new study has identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small-cell lung cancer treated with a combination of immunotherapy and low-dose radiation.
Charles F. “Chuck” Feeney ’56, founding chairman of The Atlantic Philanthropies and Cornell University’s most generous donor, died Oct. 9 in San Francisco. He was 92.
The new injectable weight-loss drug reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo.